Table 1.
Patient no. | Age, years (sex) | Sample type | Hospitalized | Susceptibility to macrolides (SNP) | MLVA type | MLVA profile | P1 gene type |
---|---|---|---|---|---|---|---|
1 | 65 (F) | BALa | yes | wt | - | - | 1 |
2 | 80 (M) | sputum | no | wt | - | - | 2 |
3 | 87 (F) | sputum | no | wt | - | - | - |
4 | 44 (M) | BALa | yes | wt | J | (3/4/5/7/2) | 1 |
5 | 32 (M) | NPSb | no | R (A2063G) | NCc | (3/0/6/6/2) | 2 |
6 | 62 (M) | NPS | no | wt | NCc | (0/0/5/6/2) | 2 |
7 | 61 (F) | NPS | no | wt | A | (1/4/5/7/2) | 1 |
8 | 20 (M) | sputum | yes | wt | NCc | (5/0/5/6/2) | 2 |
9 | 49 (M) | NPS | no | wt | NCc | (7/0/6/5/2) | 2 |
10 | 37 (F) | BALc | yes | R (A2063G) | Z | (7/4/5/7/2) | 1 |
11 | 37 (F) | NPS | no | wt | - | - | 1 |
12 | 18 (M) | NPS | yes | wt | - | - | 1 |
13 | 52 (M) | NPS | no | wt | - | - | 2 |
14 | 23 (F) | sputum | no | wt | NCc | (3/0/6/7/2) | 1 |
15 | 31 (F) | NPS | no | R (A2064G) | - | - | 2 |
a Bronchoalveolar Lavage.
b Nasopharyngeal swab.
c Not classifiable using the scheme proposed by Degrangè et al. (2009).
MLVA: multiple-locus variable-number tandem repeat analysis; R: resistant; SNP: single nucleotide polymorphism; wt: wild type.